{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:48:04Z","timestamp":1774687684562,"version":"3.50.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.autrev.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T12:03:59Z","timestamp":1400069039000},"page":"781-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hot topics in autoimmune diseases: Perspectives from the 2013 Asian Congress of Autoimmunity"],"prefix":"10.1016","volume":"13","author":[{"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.05.006_bb0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","article-title":"Systemic lupus erythematosus one disease or many?","volume":"11","author":"Agmon-Levin","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","article-title":"The epigenetics of autoimmunity","volume":"8","author":"Meda","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2013.10.001","article-title":"DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology","volume":"50","author":"Stefan","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaut.2012.12.001","article-title":"The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs","volume":"41","author":"Svendsen","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","article-title":"Treg and CTLA-4: two intertwining pathways to immune tolerance","volume":"45","author":"Walker","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/BOR.0b013e328364206f","article-title":"Epigenetics in the pathogenesis of systemic lupus erythematosus","volume":"25","author":"Altorok","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-013-1407-9","article-title":"Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk","volume":"306","author":"Debniak","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2014.05.006_bb0050","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar3807","article-title":"Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization","volume":"14","author":"Bohm","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.05.006_bb0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00251-013-0717-6","article-title":"TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development","volume":"65","author":"Perricone","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.autrev.2014.05.006_bb0060","doi-asserted-by":"crossref","first-page":"J282","DOI":"10.1016\/j.jaut.2011.11.013","article-title":"Sex affects immunity","volume":"38","author":"Pennell","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2012.12.008","article-title":"Y chromosome loss in male patients with primary biliary cirrhosis","volume":"41","author":"Lleo","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.autrev.2012.03.009","article-title":"Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers","volume":"12","author":"Sciascia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0075","article-title":"Biomarkers of lymphoma in Sjogren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","author":"Quartuccio","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.autrev.2013.06.015","article-title":"Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis","volume":"12","author":"Zhu","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.05.002","article-title":"The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes","volume":"44","author":"Boettler","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2012.07.008","article-title":"Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays","volume":"40","author":"Iorio","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","article-title":"Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice","volume":"45","author":"Katzav","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","article-title":"Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"12","author":"Sinico","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2006.12.003","article-title":"Urinary TWEAK and the activity of lupus nephritis","volume":"27","author":"Schwartz","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/ejhg.2010.197","article-title":"A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE","volume":"19","author":"Sandling","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2014.05.006_bb0115","first-page":"3053","article-title":"Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus","volume":"21","author":"Miret","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.autrev.2014.05.006_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12016-012-8342-y","article-title":"Vitamin D in systemic and organ-specific autoimmune diseases","volume":"45","author":"Agmon-Levin","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0125","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.autrev.2013.02.004","article-title":"Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality\u2014a review of recent evidence","volume":"12","author":"Pludowski","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-013-8361-3","article-title":"The implication of vitamin D and autoimmunity: a comprehensive review","volume":"45","author":"Yang","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","article-title":"Vitamin D deficiency in systemic lupus erythematosus","volume":"5","author":"Kamen","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2012.07.004","article-title":"The role of Th17\/IL-17 on eosinophilic inflammation","volume":"40","author":"Dias","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-011-8296-5","article-title":"Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity","volume":"44","author":"Axtell","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2013.08.003","article-title":"IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses","volume":"50","author":"Chong","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0160","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ni.2730","article-title":"Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation","volume":"14","author":"Garris","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ni.2552","article-title":"Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses","volume":"14","author":"Hirota","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ni.2607","article-title":"Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways","volume":"14","author":"Kim","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","article-title":"Role of IL-17 in psoriasis and psoriatic arthritis","volume":"44","author":"Raychaudhuri","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0180","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0185","article-title":"TLR2 and TLR4 in autoimmune diseases: a comprehensive review","author":"Liu","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.autrev.2014.05.006_bb0190","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2014.05.006_bb0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.05.006_bb0200","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3899\/jrheum.090108","article-title":"Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.03.002","article-title":"Neuropsychiatric disease in murine lupus is dependent on the TWEAK\/Fn14 pathway","volume":"43","author":"Wen","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0210","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.autrev.2013.07.004","article-title":"Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features","volume":"12","author":"Toledano","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000030","article-title":"Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature","volume":"26","author":"Peart","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0220","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2013.06.011","article-title":"Long-term safety of abatacept in patients with rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0225","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.autrev.2012.11.011","article-title":"The impact of the profile of biologics on treatment costs","volume":"12","author":"Leardini","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0230","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2012.08.013","article-title":"Can we reduce the dosage of biologics in spondyloarthritis?","volume":"12","author":"Olivieri","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0235","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0240","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.autrev.2013.02.005","article-title":"Is it time for biosimilars in autoimmune diseases?","volume":"12","author":"Cuadrado","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0245","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.autrev.2014.01.051","article-title":"Putting the value into biosimilar decision making: the judgment value criteria","volume":"13","author":"Mendes de Abreu","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0250","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","article-title":"Tregitope update: mechanism of action parallels IVIg","volume":"12","author":"Cousens","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2013.08.008","article-title":"CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs","volume":"47","author":"Mayer","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2013.04.001","article-title":"B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10\/Treg-dependent mechanisms","volume":"44","author":"Podojil","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2012.08.001","article-title":"NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes","volume":"40","author":"Van Belle","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0270","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.autrev.2013.01.001","article-title":"Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis","volume":"12","author":"Cutolo","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0275","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2013.07.002","article-title":"CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance","volume":"12","author":"Romo-Tena","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0280","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2012.09.001","article-title":"Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy","volume":"12","author":"Maiti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-012-8303-5","article-title":"The genetics of psoriasis and psoriatic arthritis","volume":"44","author":"Chandran","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12016-012-8306-2","article-title":"Cytokine-based therapy in psoriasis","volume":"44","author":"Mitra","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.01.001","article-title":"Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris","volume":"41","author":"Zhang","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-012-8349-4","article-title":"Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease","volume":"45","author":"Arias-Loste","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02230349","article-title":"Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis","volume":"15","author":"Spadaro","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0310","first-page":"171","article-title":"Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters","volume":"63","author":"Spadaro","year":"1996","journal-title":"Rev Rhum"},{"key":"10.1016\/j.autrev.2014.05.006_bb0315","article-title":"Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression","author":"Caetano-Lopes","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.autrev.2014.05.006_bb0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2474-13-191","article-title":"Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis","volume":"13","author":"Taylan","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2014.05.006_bb0325","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.006_bb0330","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2011-07-361279","article-title":"NRP-1 and IL-17-producing NKT cells","volume":"118","author":"Soumelis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.006_bb0335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3899\/jrheum.080964","article-title":"The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production","volume":"36","author":"Stebbings","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0340","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","article-title":"Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies","volume":"12","author":"Comarmond","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0345","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12016-011-8268-9","article-title":"Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome","volume":"44","author":"Gualtierotti","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0350","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.autrev.2012.08.002","article-title":"The clinical relevance of IgA anticardiolipin and IgA anti-beta2 glycoprotein I antiphospholipid antibodies: a systematic review","volume":"12","author":"Meijide","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2013.08.005","article-title":"Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris","volume":"47","author":"Viall","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia","volume":"28","author":"Hahn","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0365","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/08916934.2013.783025","article-title":"Antiphospholipid antibodies mediate autoimmunity against dying cells","volume":"46","author":"Andreoli","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2014.05.006_bb0370","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket454","article-title":"Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?","author":"Tam","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.05.006_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/ket469","article-title":"The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis\u2014a randomized, placebo-controlled pilot trial","author":"Tam","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.05.006_bb0380","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.coph.2013.01.003","article-title":"Inflammation and atherosclerosis: direct versus indirect mechanisms","volume":"13","author":"Rosenfeld","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0385","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.autrev.2013.10.015","article-title":"Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems","volume":"13","author":"Bizzaro","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.006_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0400","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-013-8400-4","article-title":"Adverse events following immunization with vaccines containing adjuvants","volume":"56","author":"Cerpa-Cruz","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2014.05.006_bb0405","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.2174\/09298673113209990253","article-title":"Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)\u2014animal models as a proof of concept","volume":"20","author":"Cruz-Tapias","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2014.05.006_bb0410","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1586\/eci.13.2","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum","volume":"9","author":"Vera-Lastra","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0961203311429552","article-title":"Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA)","volume":"21","author":"Israeli","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.006_bb0420","first-page":"83","article-title":"Hyperferritinemia in autoimmunity","volume":"10","author":"Zandman-Goddard","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2014.05.006_bb0425","first-page":"423","article-title":"Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis","volume":"34","author":"Yildirim","year":"2004","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.autrev.2014.05.006_bb0430","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009740310003712","article-title":"The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus","volume":"32","author":"Beyan","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0435","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12016-011-8293-8","article-title":"The therapeutic potential of epigenetics in autoimmune diseases","volume":"42","author":"De Santis","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.006_bb0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0445","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0968-0004(94)90115-5","article-title":"Proteasomes: protein degradation machines of the cell","volume":"19","author":"Peters","year":"1994","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.autrev.2014.05.006_bb0450","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/rheumatology\/ket284","article-title":"Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus","volume":"53","author":"Quartuccio","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.05.006_bb0455","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2012.05.016","article-title":"Peptide-based approaches to treat lupus and other autoimmune diseases","volume":"39","author":"Schall","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.006_bb0460","doi-asserted-by":"crossref","first-page":"e77451","DOI":"10.1371\/journal.pone.0077451","article-title":"Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.05.006_bb0465","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.006_bb0470","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.autrev.2013.01.003","article-title":"The future of immunoglobulin therapy: an overview of the 2nd international workshop on natural antibodies in health and disease","volume":"12","author":"Miescher","year":"2013","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T05:52:45Z","timestamp":1538632365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1568997214001256"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hot topics in autoimmune diseases: Perspectives from the 2013 Asian Congress of Autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}